Abound Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.23K | Sell |
32
-209
| -87% | -$14.6K | ﹤0.01% | 731 |
|
|
2025
Q1 | $16.7K | Sell |
241
-13
| -5% | -$903 | 0.01% | 325 |
|
|
2024
Q4 | $21.9K | Hold |
254
| – | – | 0.01% | 267 |
|
|
2024
Q3 | $30.3K | Buy |
254
+36
| +17% | +$4.29K | 0.01% | 230 |
|
|
2024
Q2 | $31.1K | Buy |
218
+157
| +257% | +$22.4K | 0.01% | 206 |
|
|
2024
Q1 | $7.85K | Sell |
61
-3
| -5% | -$386 | ﹤0.01% | 421 |
|
|
2023
Q4 | $6.63K | Buy |
64
+2
| +3% | +$207 | ﹤0.01% | 449 |
|
|
2023
Q3 | $5.65K | Hold |
62
| – | – | ﹤0.01% | 439 |
|
|
2023
Q2 | $5.02K | Buy |
62
+50
| +417% | +$4.05K | ﹤0.01% | 480 |
|
|
2023
Q1 | $955 | Hold |
12
| – | – | ﹤0.01% | 641 |
|
|
2022
Q4 | $813 | Buy |
+12
| New | +$813 | ﹤0.01% | 630 |
|